M. Weijtens

发表

Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

Jerome H. Kim, B. Korber, P. Earl, 2013, Cell.

Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.

M. Weijtens, D. Valerio, K. Stam, 1996, Journal of immunology.

Chimeric scFv/γ receptor‐mediated T‐cell lysis of tumor cells is coregulated by adhesion and accessory molecules

B. V. van Krimpen, M. Weijtens, M. Weijtens, 1998, International journal of cancer.

Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.

A. Hagenbeek, R. D. de Weger, A. Martens, 2004, Experimental hematology.

Monitoring of developing graft-versus-host disease mediated by herpes simplex virus thymidine kinase gene-transduced T cells.

A. Hagenbeek, T. D. de Witte, R. D. de Weger, 2003, Human gene therapy.

Preparation for a phase I/II study using autologous gene modified T lymphocytes for treatment of metastatic renal cancer patients.

C. Lamers, J. Gratama, M. Weijtens, 1998, Advances in experimental medicine and biology.

Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.

A. Hagenbeek, E. Braakman, A. Martens, 2002, Human gene therapy.

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

H. Schuitemaker, J. Custers, C. Mire, 2018, PloS one.

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Jennifer A. Johnson, J. Goudsmit, D. Barouch, 2013, The Journal of infectious diseases.

Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species

H. Schuitemaker, G. Weverling, J. Custers, 2012, PloS one.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

Jennifer A. Johnson, B. Korber, P. Earl, 2018, The Journal of infectious diseases.

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.

N. Frahm, E. Karita, M. McElrath, 2016, Annals of internal medicine.

Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.

Jennifer A. Johnson, D. Milner, D. Barouch, 2015, The Journal of infectious diseases.

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

U. Reimer, H. Wenschuh, N. Frahm, 2013, The Journal of infectious diseases.

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

H. Schuitemaker, U. Reimer, H. Wenschuh, 2015, Science.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Jennifer A. Johnson, D. Barouch, M. Seaman, 2014, The Journal of infectious diseases.

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

J W Gratama, Z. Eshhar, J. Gratama, 2000, Gene Therapy.

Onset of transcription in Patella vulgata coincides with cell cycle elongation and expression of tubulin genes

H. Goedemans, M. Weijtens, A. Daemen, 2004, Roux's archives of developmental biology.

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

J. Goudsmit, M. Seaman, M. Weijtens, 2012, Retrovirology.